Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
CD19 and BCMA CAR T-Cells by Shanghai Unicar-Therapy Bio-Medicine Technology for Leukemia: Likelihood of Approval
CD19 and BCMA CAR T-Cells is under clinical development by Shanghai Unicar-Therapy Bio-Medicine Technology and currently in Phase II for...